Unique ID issued by UMIN | UMIN000021471 |
---|---|
Receipt number | R000024766 |
Scientific Title | Dose-finding study of persimmon leaf extract to assess the suppressive effect on postprandial blood glucose levels in healthy subjects |
Date of disclosure of the study information | 2016/03/15 |
Last modified on | 2016/06/15 16:02:05 |
Dose-finding study of persimmon leaf extract to assess the suppressive effect on postprandial blood glucose levels in healthy subjects
Dose-finding study of persimmon leaf extract to assess the suppressive effect on postprandial blood glucose levels in healthy subjects
Dose-finding study of persimmon leaf extract to assess the suppressive effect on postprandial blood glucose levels in healthy subjects
Dose-finding study of persimmon leaf extract to assess the suppressive effect on postprandial blood glucose levels in healthy subjects
Japan |
Healthy adult
Adult |
Others
NO
The optimum dose of persimmon leaf hot-water extract for the suppressive effect on postprandial blood glucose levels was evaluated by analyzing the time-dependent changes in postprandial blood glucose levels, the incremental area under curves (IAUC), and glycemic indexes (GI) after intakes of the placebo, low-, and high-dose extracts with Koshihikari boiled rice in healthy subjects.
Efficacy
Time-dependent changes in postprandial blood glucose levels
Time-dependent changes in postprandial IAUC and GI
Interventional
Cross-over
Randomized
Individual
Single blind -participants are blinded
Placebo
3
Prevention
Food |
Test food-1: Low-dose extract (350 mL) and Koshihikari boiled rice(147g)
Test food-2: Low-dose extract (350 mL) and Koshihikari boiled rice(147g)
Control food: water (350 mL) colored with caramel and Koshihikari boiled rice(147g)
20 | years-old | <= |
50 | years-old | >= |
Male and Female
1.Body mass index (BMI) = <30.
2.Volunteers with no glucose intolelance in the past yesr.
3.Fasting plasma glucose 70-110mg/dl
4.Volunteers being able to make self-judgent to particupate in this study and giving written informed consent.
5.Volunteers having screening test results judged to be appropriate for this study by investigator.
1.Volunteers having severe history of the diseases (liver,kidney,hert,blood) judged to be inappropriate for this study.
2.Volunteers received gastrectomy,enterectomy,and gastro-intestinal dedeases,judged to be inappropriate for this study.
3.Volunteers having risk of diabetes mellitus (fasting plasma glucose > = 110mg/dl and HbA1c > = 5.9%).
4.Volunteers rejected participating in this study by chief investigater.
10
1st name | |
Middle name | |
Last name | Kenichi Watanabe |
Niigata Universty of Pharmacy and Applied Life Sciences
Laboratory of Clinical pharmacology
265-1, Higashijima, Akiha-ku, Niigata City
0250-25-5267
watanabe@nupals.ac.jp
1st name | |
Middle name | |
Last name | Niigata Bio-Research Park, Inc |
Niigata Bio-Research Park, Inc
Business promotion division
316-2 Higashijima, Akiha-ku, Niigata, 956-0811, Japan
0250-25-1196
nbrp-food-navi@nbrp.co.jp
Niigata Bio-Research Park, Inc
Niigata Bio-Research Park, Inc
Profit organization
NO
2016 | Year | 03 | Month | 15 | Day |
Unpublished
Completed
2016 | Year | 03 | Month | 04 | Day |
2016 | Year | 03 | Month | 15 | Day |
2016 | Year | 03 | Month | 15 | Day |
2016 | Year | 06 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024766